Skip to main content

MDL Court Frames Guidelines For Testing Asbestos In Talc

MDL Court Frames Guidelines For Testing Asbestos In Talc

MDL Court Frames Guidelines For Testing Asbestos In Talc

Introduction

On November 1, Special Master Joel Pisano, appointed by the U.S. District Judge Freda L. Wolfson presiding over all federal talcum powder lawsuits, approved a supplemental order with regards to the testing procedures for Johnson & Johnson's (J&J) Baby Powder samples from the recalled lots.

The order indicates that J&J should notify plaintiffs that additional samples for independent testing will not be available, if the testing associated with recent recall uses up all the samples. It further states to preserve the samples and recalled bottles of baby powder returned by consumers and an appropriate protocol for dividing and selecting such samples should be raised with the court.

The last month's recall impacted 33,000 bottles after the FDA found evidence of asbestos in a sample tested. The lawsuits are consolidated under multidistrict litigation MDL No. 2738 ( In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation). Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Johnson's Baby Powder, one of the most popular products containing talcum powder, is linked to increasing a woman's risk of ovarian cancer if she uses it regularly in the genital area. In a few cases, the cancer tissue was studied using an electron microscope and was found to have talc in it, which supported the claim that the cancer was caused by the body powder and increases the talc-related cancer risk.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!